(RNAC) Cartesian Therapeutics - Performance -55.2% in 12m
Compare RNAC with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-82.43%
#135 in Group
Rel. Strength
11.54%
#7039 in Universe
Total Return 12m
-55.18%
#110 in Group
Total Return 5y
-89.44%
#96 in Group
P/E -
(?) Percentile in Group
P/E Forward 25.5
73th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -25.13%
26th Percentile in Group
12m Total Return: RNAC (-55.2%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: RNAC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RNAC
Total Return (including Dividends) | RNAC | XBI | S&P 500 |
---|---|---|---|
1 Month | 9.45% | 11.81% | 13.81% |
3 Months | -43.71% | -13.61% | -6.30% |
12 Months | -55.18% | -12.29% | 10.65% |
5 Years | -89.44% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | RNAC | XBI | S&P 500 |
1 Month | 10.3% | 72.9% | 83% |
3 Months | -89.6% | -83% | -75.3% |
12 Months | -44.2% | -51.6% | 50.1% |
5 Years | -89.3% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #133 | -2.10% | -3.83% |
3 Month | #161 | -34.8% | -39.9% |
12 Month | #110 | -48.9% | -59.5% |
5 Years | #103 | -85.9% | -94.9% |
FAQs
Does RNAC Cartesian Therapeutics outperforms the market?
No,
over the last 12 months RNAC made -55.18%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months RNAC made -43.71%, while XBI made -13.61%.
Over the last 3 months RNAC made -43.71%, while XBI made -13.61%.
Performance Comparison RNAC vs Indeces and Sectors
RNAC vs. Indices RNAC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -16.3% | -4.36% | -44.9% | -65.8% |
US NASDAQ 100 | QQQ | -16.5% | -7.91% | -45.1% | -66.8% |
US Dow Jones Industrial 30 | DIA | -16.7% | -0.54% | -44.6% | -62.9% |
German DAX 40 | DAX | -16.2% | -5.51% | -71.1% | -80.9% |
Shanghai Shenzhen CSI 300 | CSI 300 | -18.4% | -2.38% | -45.6% | -62.6% |
Hongkong Hang Seng | HSI | -19.4% | -10.5% | -53.2% | -68.9% |
India NIFTY 50 | INDA | -11.3% | 4.61% | -45.3% | -55.0% |
Brasil Bovespa | EWZ | -17.3% | -7.79% | -53.6% | -46.9% |
RNAC vs. Sectors RNAC is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -16.9% | -3.96% | -51.9% | -76.7% |
Consumer Discretionary | XLY | -16.6% | -4.78% | -43.9% | -69.5% |
Consumer Staples | XLP | -15.4% | 2.86% | -51.8% | -64.3% |
Energy | XLE | -16.1% | 2.69% | -38.3% | -45.7% |
Financial | XLF | -17.4% | -4.07% | -52.0% | -77.6% |
Health Care | XLV | -13.3% | 8.58% | -39.9% | -51.1% |
Industrial | XLI | -18.0% | -7.37% | -46.3% | -66.2% |
Materials | XLB | -16.1% | -4.11% | -40.0% | -50.0% |
Real Estate | XLRE | -14.9% | -2.09% | -45.6% | -70.6% |
Technology | XLK | -17.3% | -11.8% | -42.0% | -62.3% |
Utilities | XLU | -16.3% | -0.14% | -52.5% | -72.7% |
Aerospace & Defense | XAR | -18.2% | -11.7% | -56.4% | -82.5% |
Biotech | XBI | -9.67% | -2.36% | -24.7% | -42.9% |
Homebuilder | XHB | -16.7% | -2.03% | -31.7% | -47.6% |
Retail | XRT | -18.2% | -5.20% | -40.6% | -53.7% |